Pages that link to "Q51233474"

The following pages link to Wear debris inhibition of anti-osteoclastogenic signaling by interleukin-6 and interferon-gamma. Mechanistic insights and implications for periprosthetic osteolysis (Q51233474):

Displaying 30 items.

• Development of a macromolecular prodrug for the treatment of inflammatory arthritis: mechanisms involved in arthrotropism and sustained therapeutic efficacy (Q22000845) (← links)
• Prevention of wear particle-induced osteolysis by a novel V-ATPase inhibitor saliphenylhalamide through inhibition of osteoclast bone resorption (Q28482246) (← links)
• Calcineurin/NFAT pathway mediates wear particle-induced TNF-α release and osteoclastogenesis from mice bone marrow macrophages in vitro. (Q33551921) (← links)
• Reduction of particle-induced osteolysis by interleukin-6 involves anti-inflammatory effect and inhibition of early osteoclast precursor differentiation (Q33946711) (← links)
• Alpha-Calcitonin Gene-Related Peptide Can Reverse The Catabolic Influence Of UHMWPE Particles On RANKL Expression In Primary Human Osteoblasts (Q34156735) (← links)
• Effects of alpha-calcitonin gene-related peptide on osteoprotegerin and receptor activator of nuclear factor-κB ligand expression in MG-63 osteoblast-like cells exposed to polyethylene particles. (Q34332098) (← links)
• The relative timing of exposure to phagocytosable particulates and to osteoclastogenic cytokines is critically important in the determination of myeloid cell fate (Q34470363) (← links)
• Interaction of Materials and Biology in Total Joint Replacement - Successes, Challenges and Future Directions (Q34751110) (← links)
• Suppressor of cytokine signalling protein SOCS3 expression is increased at sites of acute and chronic inflammation (Q34762453) (← links)
• The central role of wear debris in periprosthetic osteolysis (Q36796472) (← links)
• Development of polymeric nanocarrier system for early detection and targeted therapeutic treatment of peri-implant osteolysis (Q36807847) (← links)
• Alternative macrophage activation in periprosthetic osteolysis (Q37118773) (← links)
• Adenovirus-mediated siRNA targeting TNF-α and overexpression of bone morphogenetic protein-2 promotes early osteoblast differentiation on a cell model of Ti particle-induced inflammatory response in vitro (Q37371220) (← links)
• Periprosthetic osteolysis: genetics, mechanisms and potential therapeutic interventions (Q38044786) (← links)
• Chronic inflammation in biomaterial-induced periprosthetic osteolysis: NF-κB as a therapeutic target. (Q38148877) (← links)
• How has the introduction of new bearing surfaces altered the biological reactions to byproducts of wear and modularity? (Q38221370) (← links)
• Wear Particles Impair Antimicrobial Activity Via Suppression of Reactive Oxygen Species Generation and ERK1/2 Phosphorylation in Activated Macrophages (Q38921246) (← links)
• p38 Signaling in titanium particle-induced MMP-2 secretion and activation in differentiating MC3T3-E1 cells (Q39081831) (← links)
• Inhibition of titanium particle-induced inflammation by the proteasome inhibitor bortezomib in murine macrophage-like RAW 264.7 cells (Q39377674) (← links)
• Comprehensive profiling analysis of actively resorbing osteoclasts identifies critical signaling pathways regulated by bone substrate (Q41939951) (← links)
• Inhibitory effect ofquercetinon titaniumparticle-inducedendoplasmic reticulum stress (ERS)-related apoptosisandin vivoosteolysis (Q42373772) (← links)
• The effects of icariine concentration on osteoclasts bone resorption induced by titanium particles in vitro (Q42641333) (← links)
• Type-2 cannabinoid receptor regulates proliferation, apoptosis, differentiation, and OPG/RANKL ratio of MC3T3-E1 cells exposed to Titanium particles (Q42834637) (← links)
• Metal wear particles: What we know, what we do not know, and why. (Q43193692) (← links)
• Enhancement of osteoblast differentiation that is inhibited by titanium particles through inactivation of NFATc1 by VIVIT peptide (Q45366983) (← links)
• Protection against titanium particle-induced inflammatory osteolysis by the proteasome inhibitor bortezomib in vivo (Q51355256) (← links)
• Inhibition of p38 mitogen-activated protein kinase down-regulates the inflammatory osteolysis response to titanium particles in a murine osteolysis model. (Q54499630) (← links)
• Macrophage inhibits the osteogenesis of fibroblasts in ultrahigh molecular weight polyethylene (UHMWPE) wear particle-induced osteolysis (Q64080896) (← links)
• Therapeutic Potential of the Proteasome Inhibitor Bortezomib on Titanium Particle-Induced Inflammation in a Murine Model (Q85029520) (← links)
• Lithium chloride with immunomodulatory function for regulating titanium nanoparticle-stimulated inflammatory response and accelerating osteogenesis through suppression of MAPK signaling pathway (Q90397507) (← links)